Literature DB >> 350569

A comparative trial of oxantel-pyrantel and mebendazole in multiple helminth infection in school children.

A S Dissanaike.   

Abstract

In a pilot study in 17 children, oxantel-pyrantel as one single dose of 10 to 20mg/kg of each, gave good results in ascariasis but poor cure rates in both trichuriasis and necatoriasis. However in the latter groups the infection was extremely heavy. In a controlled trial in 51 children, using oxantel-pyrantel at the same dose, but given daily for 3 consecutive days, or mebendazole 100mg twice daily for 3 days, the drugs gave similar response rates. Both gave 100% cure rates, as assessed by the absence of ova by both Beaver and brine-flotation techniques, in Ascaris lumbricoides infection. The percentage cures and egg reduction rates were 66.7 and 94.5 in trichuriasis and 53 and 93.6 in necatoriasis respectively. Those for mebendazole were 52 and 91.2 in trichuriasis and 37.5 and 89.7 in necatoriasis. Oxante-pyrantel treatment was associated with more cures, and a marginally greater reduction in ovum excretion than mebendazole but the differences were not statistically significant. No side-effects were seen with either treatment.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 350569     DOI: 10.2165/00003495-197800151-00015

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  7 in total

1.  Clinical trial with a new anti-Trichuris drug, trans-1,4,5,6 tetrahydro-2-(3-hydroxystyryl)-1-methyl pyrimidine (CP-14,445).

Authors:  V Zaman; N N Sabapathy
Journal:  Southeast Asian J Trop Med Public Health       Date:  1975-03       Impact factor: 0.267

2.  Treatment for trichuriasis with oxantel.

Authors:  E G Garcia
Journal:  Am J Trop Med Hyg       Date:  1976-11       Impact factor: 2.345

3.  Trans-1,4,5,6-tetrahydro-2-(3-hydroxystyryl)-1-methyl pyrimidine (CP-14,445), a new antiwhipworm agent.

Authors:  H L Howes
Journal:  Proc Soc Exp Biol Med       Date:  1972-02

4.  Therapeutic evaluation of oxantel pamoate (1, 4, 5, 6-tetrahydro-1-methyl-2-[trans-3-hydroxystyryl] pyrimidine pamoate) in severe Trichuris trichiura infection.

Authors:  E L Lee; N Iyngkaran; A W Grieve; M J Robinson; A S Dissanaike
Journal:  Am J Trop Med Hyg       Date:  1976-07       Impact factor: 2.345

5.  Clinical Trial Of Oxantel Pamoate(Cp-14, 445) On Trichocephalus Trichiurus Infection.

Authors:  Soon Hyung Lee; Byong Seol Seo; Seung Yull Cho; Shin Yong Kang
Journal:  Kisaengchunghak Chapchi       Date:  1976-06

6.  Anthelmintic effect of oxantel pamoate and pyrantel pamoate suspension against intestinal nematode infestations.

Authors:  Han Jong Rim; Chang Yong Won; Sung Ik Lee; Jung Kyoo Lim
Journal:  Kisaengchunghak Chapchi       Date:  1975-12

7.  Clinical trial with pyrantel pamoate (Combantrin) in ancylostomiasis.

Authors:  S R Rao; S Sudarshan; K J Murthy; F M Farooq
Journal:  J Assoc Physicians India       Date:  1973-10
  7 in total
  4 in total

1.  Oxantel-pyrantel in various regimens for the treatment of soil transmitted helminthiasis in rural and urban communities.

Authors:  B D Cabrera; F S Sy
Journal:  Drugs       Date:  1978       Impact factor: 9.546

2.  Evaluation of the efficacy of pyrantel-oxantel for the treatment of soil-transmitted nematode infections.

Authors:  Marco Albonico; Quentin Bickle; Hamad J Haji; Mahdi Ramsan; Khatib J Khatib; Antonio Montresor; Lorenzo Savioli; Martin Taylor
Journal:  Trans R Soc Trop Med Hyg       Date:  2002 Nov-Dec       Impact factor: 2.184

Review 3.  Preclinical and Clinical Characteristics of the Trichuricidal Drug Oxantel Pamoate and Clinical Development Plans: A Review.

Authors:  Marta S Palmeirim; Sabine Specht; Ivan Scandale; Irene Gander-Meisterernst; Monika Chabicovsky; Jennifer Keiser
Journal:  Drugs       Date:  2021-04-30       Impact factor: 9.546

4.  Activity of oxantel pamoate monotherapy and combination chemotherapy against Trichuris muris and hookworms: revival of an old drug.

Authors:  Jennifer Keiser; Lucienne Tritten; Angelika Silbereisen; Benjamin Speich; Roberto Adelfio; Mireille Vargas
Journal:  PLoS Negl Trop Dis       Date:  2013-03-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.